Current Cytokines News and Events

Current Cytokines News and Events, Cytokines News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 22 | 876 Results
New strategy blocks chronic lung disease in mice
A new study from Washington University School of Medicine in St. Louis has uncovered a previously unknown role for exosomes in inflammatory respiratory diseases. The study has implications for finding new therapies. Exosomes are tiny compartments released from cells that carry different types of cargo, including inflammatory chemicals called cytokines that can drive lung disease. (2021-02-23)

Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection
The @Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for SARS-CoV-2 infection leading also to suppression of SARS-CoV-2-S pseudovirus infection of human cells (2021-02-22)

Antibody response may drive COVID-19 outcomes
Researchers at the Ragon Institute of MGH, MIT and Harvard and Massachusetts General Hospital show that levels of specific antibodies developed in the immune response may influence COVID-19 outcomes in both children and adults. (2021-02-18)

Mimicking a chronic immune response changes the brain
Abnormal production of Inflammatory cytokines by the immune system is responsible for a host of autoimmune disorders. One important cytokine is IL-17A, which is also involved in neurological diseases. Researchers at Tsukuba University in Japan made a mouse model of chronically high IL-17A and to study its effect on the brain. They show that it leads to reduced activity and density of microglia in the brain's hippocampus, but no obvious memory deficits. (2021-02-17)

Oncotarget: Targeting engineered cytokine with interleukin to the neovasculature of tumors
''The results suggest that this product, or similar fusion proteins featuring an N-terminal fusion in the diabody format, may deserve to be investigated in clinical trials'' (2021-02-15)

New synthetic peptides could attenuate atherosclerosis
Atherosclerosis, a lipid-triggered chronic inflammatory disease of our arteries, is the main cause of strokes and heart attacks. An international team of researchers led by the Technical University of Munich (TUM) and the LMU University Hospital has developed novel synthetic peptides that can help to prevent atherosclerosis in vitro, that is in the test tube, as well as in animal models. (2021-02-12)

Sweet coating for sour bones
Scientists invent a bioactive coating to improve the function of titanium implants in osteoporotic bones. This coating, comprising a chemically-modified glycan, can sequentially turn on and off inflammation on titanium surface upon implantation. This modulation stimulates the body's immune system to promote bone healing in an effective and safe way, without addition of bone-forming genes or drugs, according to the data from a rat osteoporotic model. (2021-02-12)

Substance in the blood of pregnant women fights pathological immune reaction
Scientists studied the effect of trophoblastic β1-glycoprotein in the blood of pregnant women on pro-inflammatory immune cells. Thanks to trophoblastic β1-glycoprotein, a woman's body does not adversely react to the fetus and supports its normal development until birth. It turned out that trophoblastic β1-glycoproteins also suppressed the development of pro-inflammatory lymphocytes and reduced their activity. (2021-02-10)

MSK researchers learn what's driving 'brain fog' in people with COVID-19
A unique collaboration among experts from several areas within MSK leads to findings about how inflammation appears to be driving the neurologic effects seen in some COVID-19 patients. (2021-02-08)

Study identifies noncoding RNA involved in immune response and sepsis
When the body's immune response to an infection gets out of control, the result can be sepsis, a life-threatening condition in which an overwhelming inflammatory response can lead rapidly to failure of multiple organs and death. In a new study, researchers at UC Santa Cruz have identified a long noncoding RNA (lncRNA) molecule that regulates the expression of pro-inflammatory genes in immune system cells called macrophages and affects the susceptibility of mice to septic shock. (2021-02-01)

3-D printed Biomesh minimizes hernia repair complications
A newly-designed 3D-printed Biomesh effectively minimized postsurgical complications of hernia repair in an animal model. (2021-01-25)

Immunology - Functionality of immune cells in early life
A study by Ludwig-Maximilians-Universitaet (LMU) in Munich researchers shows that putatively immature dendritic cells found in young children are able to induce robust immune responses. The results could lead to improved vaccination protocols. (2021-01-21)

Study identifies a nonhuman primate model that mimics severe COVID-19 similar to humans
Aged, wild-caught African green monkeys exposed to the SARS-CoV-2 virus developed acute respiratory distress syndrome (ARDS) with clinical symptoms similar to those observed in the most serious human cases of COVID-19, report researchers in The American Journal of Pathology, published by Elsevier. This is the first study to show that African green monkeys can develop severe clinical disease after SARS-CoV-2 infection, suggesting that they may be useful models for the study of COVID-19 in humans. (2021-01-19)

Turbo boosters for the immune system
Immunologist Prof. Dr. Olaf Groß of the Medical Center - University of Freiburg receives a Proof of Concept Grant from the European Research Council (ERC) for his project IMMUNOSTIM. (2021-01-11)

Severe sepsis predicted by common protein
A sugar-binding protein could fuel terrible inflammation and worsen sepsis, a disease that kills more than 270,000 people every year in the US alone, reports a team of researchers led by immunologists at UConn Health. (2021-01-04)

Common diabetes drug may trigger rare complications for COVID-19 patients
An uptick in a particular type of DKA called euDKA at Brigham and Women's Hospital during the COVID-19 pandemic has led researchers to hypothesize that diabetes patients on glucose-lowering drugs may be at increased risk for euDKA when they contract COVID-19. The observational case series was published in The American Association of Clinical Endocrinologists Clinical Case Reports. (2020-12-24)

Maternal Immune Activation Induces Sustained Changes in Fetal Microglia Motility
Researchers at the Kobe University Graduate School of Medicine have revealed that alterations in fetal microglia resulting from maternal inflammation could contribute towards the onset of developmental and psychiatric disorders. These results can help clarify how changes in microglial process motility affect the development of the neural network, thus contributing towards the treatment of these disorders. (2020-12-22)

Pacify the protein and win over a disease
Will it be enough to pacify the activity of certain proteins in order to hold back the development of many dangerous diseases including Alzheimer's disease? An article on a breaking through discovery has just been published in PNAS, a prestigious magazine of American Academy of Sciences. Its first author is Karolina Mikulska-Ruminska, Dr., a biophysicist from Nicolaus Copernicus University in Torun (Poland). The article refers to the mechanisms of the activities of the immune system under inflammatory conditions. (2020-12-21)

New therapeutic target pinpointed for stomach cancer
WEHI researchers have identified a key molecular regulator, TNF, which is involved in the progression and spread of stomach cancer, suggesting a potential new approach to treat this devastating disease. (2020-12-16)

RUDN immunologists developed method for assessing inflammation in respiratory tract diseases
A team of immunologists from RUDN University suggested a new tool to control inflammation levels in asthma patients with accompanying diseases. To obtain information about disease flow and risks of complications, they used different types of cytokines found in the patients' nasal swabs. (2020-12-05)

Research shows bariatric surgery may reduce severity of COVID-19 in patients with obesity
A Cleveland Clinic study shows that among patients who have obesity and who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission. The results were published in the journal of Surgery for Obesity and Related Diseases. (2020-11-24)

Ancient interleukins 2, 15, and 15-like exhibited distinct functions but all bound IL-15Ra
Interleukin-15-like (IL-15L) is found in both fish and mammals and may be the last remaining cytokine shared between those species for which the function had not been determined yet. Scientists now report the first functional analysis of cytokine IL-15L which, similar to related IL-15 and primitive IL-2, forms a complex with receptor chain IL-15Ra, but in contrast to these cytokines selectively induces a type 2 immune response. (2020-11-20)

Diabetes, hypertension may increase risk of COVID-19 brain complications
Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a study being presented at the annual meeting of the Radiological Society of North America (RSNA). The researchers said these potentially life-threatening findings were more common in patients with hypertension and diabetes. (2020-11-18)

In the lab, St. Jude scientists identify possible COVID-19 treatment
Immunologists have determined the process driving life-threatening inflammation, lung damage and organ failure in patients with COVID-19, sepsis and other inflammatory disorders suggesting possible treatment using existing drugs. (2020-11-18)

Study explores sleep apnea, autoimmune disease link
New research by University of Georgia scientists sheds light on why people with obstructive sleep apnea may have associated autoimmune disorders. The results could lead to better approaches to treatment and possibly new drug therapies. (2020-11-17)

Antidepressant may prevent severe COVID-19, trial suggests
The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from the University of Virginia School of Medicine suggests. (2020-11-13)

Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
A study by researchers at Washington University School of Medicine in St. Louis and St. Jude Children's Research Hospital in Memphis showed that, contrary to expectation, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients. (2020-11-13)

Cytokine storms play a limited role in moderate-to-severe COVID-19
St. Jude and Washington University researchers have discovered new characteristics that differentiate the response of COVID-19 from flu. (2020-11-13)

Uracil switch in SARS-CoV-2 genome alters innate immune responses
Our bodies could be inducing mutations in the COVID-19 virus that activate immune cells to increase the production of pro-inflammatory molecules. (2020-11-11)

Rapid changes in biomarker of inflammation may be a key predictor of COVID-19 outcomes
Brigham and Women's Hospital researchers analyzed patients' levels of inflammation, known to be associated with severity of illness, by looking at C-reactive protein (CRP) trends in 100 COVID-19 patients admitted to the hospital. They found that a rapid rise in CRP levels during the first 48-to-72 hours of hospitalization was predictive of subsequent respiratory deterioration and intubation, while steadier CRP levels were observed in patients whose condition remained stable. (2020-11-05)

Aged cell variations may control health and onset of age-related diseases
Researchers from Kumamoto University, Japan have proposed that cellular senescence variations during the aging process could lead to control of health and onset of age-related diseases. Based on the characteristics of the secretion of inflammatory cytokines released by aged cells, they hypothesize that there are at least four distinct states of cellular senescence, and that these four states arise from coordinated metabolic and epigenomic changes. (2020-10-26)

Duke-NUS study uncovers why bats excel as viral reservoirs without getting sick
Study confirms bats adopt multiple strategies to reduce pro-inflammatory responses, thus mitigating potential immune-mediated tissue damage and disease. Findings provide important insights for medical research on human diseases. (2020-10-26)

PTSD and alcohol abuse go hand-in-hand, but males and females exhibit symptoms differently
Through intricate experiments designed to account for sex-specific differences, scientists at Scripps Research have collaborated to zero-in on certain changes in the brain that may be responsible for driving alcohol abuse among people with PTSD. In studies with rodents, researchers found that males and females exhibit their own distinct symptoms and brain features of PTSD and alcohol use disorder. Such differences are not typically accounted for in laboratory-based studies yet could lead to more successful clinical treatments. (2020-10-23)

Type 1 diabetes: Tannic acid encapsulation protects transplanted islets from rejection
One therapy for Type 1 diabetes is promising -- transplanting pancreatic islets from cadavers -- but a need for immunosuppression and a reactivated autoimmunity lead to low graft viability and function after five years. Now researchers show that a protective coating of alternating layers of two biopolymers delays allograft and autoimmune-mediated rejection in mouse models of T1D. (2020-10-22)

Oncotarget: Th1 cytokines potentiate apoptosis of breast cancer cells and suppress tumor growth
Volume 11, Issue 30 of Oncotarget reported that previously, the authors showed that anti-estrogen drugs combined with a dendritic cell-based anti-HER-2 vaccine known to induce strong Th1-polarized immunity dramatically improved clinical response rates in patients with HER-2pos/ERpos early breast cancer. (2020-10-18)

Blood test could identify COVID-19 patients at risk of 'cytokine storm' hyperinflammation
Southampton researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their immune systems' responses. (2020-10-14)

Boosting chickens' own immune response could curb disease
Broiler chicken producers the world over are all too familiar with coccidiosis, a parasite-borne intestinal disease that stalls growth and winnows flocks. Various approaches, developed over decades, have been used to control coccidiosis, but the disease remains widespread. Recent research from the University of Illinois supports the use of immunomodulatory and antioxidant feed additives to reduce the effects of coccidiosis. (2020-10-07)

Biomedical sciences researchers find new way to prevent and cure rotavirus, other viral infections
A combination of two substances secreted by the immune system can cure and prevent rotavirus infection, as well as potentially treat other viral infections that target epithelial cells, which cover body surfaces such as skin, blood vessels, organs and the urinary tract, according to researchers in the Institute for Biomedical Sciences at Georgia State University. (2020-10-02)

Common antioxidant enzyme may provide potential treatment for COVID-19
Catalase, a naturally occurring enzyme, holds potential as a low-cost therapeutic drug to treat COVID-19 symptoms and suppress the replication of coronavirus inside the body. (2020-09-29)

High-fibre diet, low level inflammation: sidestepping the effects of radiation
Loved or hated, the humble oat could be the new superfood for cancer patients as international research shows a diet rich in fibre could significantly reduce radiation-induced gut inflammation. (2020-09-29)

Page 1 of 22 | 876 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.